Inventor
CZABANIUK LARA C
US7 patents
Patents
7 patentsUS11608344B2Mar 21, 2023
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
AMGEN INC4 citations83
US11718617B2Aug 8, 2023
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of use
AMGEN INC4 citations73
US11912711B2Feb 27, 2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
AMGEN INC3 citations72
US11884675B2Jan 30, 2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
AMGEN INC3 citations72
US12319691B2Jun 3, 2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
AMGEN INC0 citations61
US12252489B2Mar 18, 2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
AMGEN INC0 citations61
US12428425B2Sep 30, 2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
AMGEN INC0 citations60